William Blair Reiterates Outperform Rating on Seagen (SGEN) Following Results from cohort K of the Phase Ib/II EV-103, Offers Comments
Tweet Send to a Friend
William Blair analyst Andy Hsieh reiterated an Outperform rating and {REMOVEPT} price target on Seagen (NASDAQ: SGEN).The analyst comments "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
